ATH686 is primarily utilized in the field of medical research, particularly in the development of treatments for neurodegenerative diseases. Its application is focused on modulating specific biological pathways that are implicated in conditions such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS). Researchers are exploring its potential to inhibit the aggregation of toxic proteins, which is a hallmark of these diseases. Additionally, ATH686 is being investigated for its neuroprotective properties, which could help in preserving neuronal function and slowing disease progression. Its role in enhancing cellular mechanisms that promote the clearance of damaged proteins is also a significant area of study. The compound's ability to cross the blood-brain barrier makes it a promising candidate for central nervous system-targeted therapies. Ongoing preclinical studies aim to further elucidate its efficacy and safety profile, paving the way for potential clinical trials in the future.